10 06 2021
The regime’s embarrassment should be increasing now that other countries are reporting that Thailand’s AstraZeneca production is severely delayed.
Reuters reports that, in addition to the Philippines, both Malaysia and Taiwan are saying deliveries of AstraZeneca vaccines manufactured in Thailand will be delayed. AstraZeneca reportedly made the king’s Siam Bioscience the production site for much of Southeast Asia.
Clipped from The Rand Blog
The report states that “AstraZeneca’s distribution plans in Southeast Asia … depends on 200 million doses made by Siam Bioscience, a company owned by Thailand’s king that is making vaccines for the first time.” It adds:
AstraZeneca says working with Southeast Asian nations on vaccine deliveries
FILE PHOTO: A health worker prepares a dose of AstraZeneca COVID-19 vaccine against the coronavirus disease (COVID-19) as Thailand start mass inoculation at a gymnasium inside Siam Paragon shopping centre, Bangkok, Thailand June 7, 2021. REUTERS/Soe Zeya Tun/File Photo reuters tickers
This content was published on June 10, 2021 - 08:40
June 10, 2021 - 08:40
BANGKOK (Reuters) - AstraZeneca says it is working closely with Southeast Asia governments to ensure its COVID-19 vaccine is supplied as quickly as possible , after reported delays in deliveries of orders from a Thai plant owned by the country s powerful king.
Thursday, 10 Jun 2021 03:54 PM MYT
A nurse holds up a dose of the AstraZeneca Covid-19 vaccine at the World Trade Centre Kuala Lumpur May 5, 2021. ― Picture by Ahmad Zamzahuri
Follow us on Instagram and subscribe to our Telegram channel for the latest updates.
BANGKOK, June 10 AstraZeneca says it is working closely with South-east Asia governments to ensure its Covid-19 vaccine is supplied “as quickly as possible”, after reported delays in deliveries of orders from a Thai plant owned by the country’s powerful king.
Malaysia and Taiwan this week became the latest in the region to warn they expected delays in deliveries of AstraZeneca vaccines manufactured in Thailand.